戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 reduce but do not eliminate the risk of both syncopal and life-threatening cardiac events in adult pa
2 orthostasis but deteriorates in patients and syncopal control subjects immediately before and after V
3 t deteriorated significantly in patients and syncopal control subjects in the minutes before (P=0.027
4 tailed study of the pathophysiology of these syncopal disorders and more aggressive pursuit of carefu
5 Of these, 9 (20%) had experienced at least 1 syncopal episode before the fatal event.
6 owest risk was found in patients with only 1 syncopal episode occurring before the start of beta-bloc
7               While driving, 2 percent had a syncopal episode, 11 percent had dizziness or palpitatio
8  presented to the emergency department for a syncopal episode.
9  presented to the emergency department for a syncopal episode.
10        A 50-year-old white man with repeated syncopal episodes after exercise had a cardiac arrest an
11               Despite pacing, he had several syncopal episodes attributed to ventricular dysrhythmias
12                                The number of syncopal episodes before therapy was 4.4 +/- 4.8.
13 y, for life-threatening events; those with 1 syncopal episodes in the last 2 years had an adjusted HR
14 , 7.0-19.5; P<.001) and those with 2 or more syncopal episodes in the last 2 years had an adjusted HR
15 ients were >/=40 years, had experienced >/=3 syncopal episodes in the previous 2 years.
16 2 months of follow-up or when a maximum of 3 syncopal episodes occurred within 1 month.
17                                     Multiple syncopal episodes occurring before initiation of beta-bl
18                 The upright posture provokes syncopal episodes that prevent patients from standing an
19  point she was hospitalized because of three syncopal episodes that were not related to exercise.
20                                   First-time syncopal episodes usually occur in adults of working age
21                  The mean number of previous syncopal episodes was 12 (range 9 to 20).
22                The median number of previous syncopal episodes was 6; asystolic response to tilt test
23 ients with >/=50% reduction in the number of syncopal episodes was 72% (95% confidence interval [CI]:
24 the mainstays of diagnosis and treatment for syncopal episodes, differentiation of syncope from life-
25  and their management, especially related to syncopal episodes, remains unclear.
26  a structurally normal heart and unexplained syncopal episodes.
27 nital sensorineural deafness associated with syncopal episodes.
28 nt is congenitally deaf-mute, with recurrent syncopal events and a greatly prolonged QTc interval.
29 nder, QTc interval > or =500 ms, and interim syncopal events during follow-up after age 18 years were
30                  Compared with those with no syncopal events in the last 10 years, patients with 1 or
31  follow-up period, but there were much fewer syncopal events than falls-28 episodes in paced patients
32 lcohol and, in particular, for understanding syncopal events that occur in association with alcohol i
33                                              Syncopal events were also reduced during the follow-up p
34 arily lead to the phobia because of repeated syncopal events.
35         Alcohol consumption may be linked to syncopal events.
36  ICD therapy are at very low risk for future syncopal ICD therapy.
37 ion that can lead to ventricular standstill, syncopal injury, and sudden cardiac death, and current e
38                                        A pre-syncopal limited progressive lower-body negative pressur
39                                              Syncopal patients had similarly poor outcomes compared w
40                                              Syncopal patients presented with higher right atrial pre
41                                              Syncopal patients with a known or provisional diagnosis
42                                           In syncopal patients, the higher level of plasma epinephrin
43 /collapse and, thereby, has improved care of syncopal patients.
44 es) and inappropriate shocks, mortality, and syncopal rate (secondary outcomes).
45  blood donation has some attendant risk, and syncopal reactions are more common among the youngest do
46 ive studies have been published on vasovagal syncopal reactions, antecubital nerve injuries (irritati
47              Even in untreated patients, the syncopal recurrence burden was low.
48 e no-pacemaker arm, the median time to first syncopal recurrence was 5 months, with a rate of 0.44 pe
49 efficacy of cardiac pacing for prevention of syncopal recurrences in patients with neurally mediated
50  to determine whether pacing therapy reduces syncopal recurrences in patients with severe asystolic n
51 ate hysteresis with no implant in respect to syncopal recurrences in patients with severe cardioinhib
52 e measured manually from standard ECGs in 10 syncopal rTOF patients (21.4 +/- 4.6 years after repair;
53                          All patients had >2 syncopal spells and a Calgary Syncope Symptom Score >-3.
54 emale, median age 30 years) with a median 15 syncopal spells over a median of 9 years equally to flud
55                                              Syncopal subjects with carotid sinus syndrome were more
56 ly recorded, in addition to incidence of pre-syncopal symptoms (PSS).
57 , 6-min walk distance, or etiology of PAH in syncopal versus nonsyncopal patients.
58  cardiac arrest, 17.0% (n=1399, 238 deaths); Syncopal VT, 21.2% (n=598, 127 deaths); Symptomatic VT,
59 as were the categories of VF cardiac arrest, Syncopal VT, and Symptomatic VT, below.